These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22613854)

  • 1. Histopathological patterns indicative of distinct adverse drug reactions.
    Kerl K
    Chem Immunol Allergy; 2012; 97():61-78. PubMed ID: 22613854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced cutaneous pathology.
    Ramdial PK; Naidoo DK
    J Clin Pathol; 2009 Jun; 62(6):493-504. PubMed ID: 19155238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
    Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
    Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies.
    Laga AC; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2010 Aug; 32(6):568-73. PubMed ID: 20520526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists.
    Asarch A; Gottlieb AB; Lee J; Masterpol KS; Scheinman PL; Stadecker MJ; Massarotti EM; Bush ML
    J Am Acad Dermatol; 2009 Jul; 61(1):104-11. PubMed ID: 19539844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adverse cutaneous drug reactions].
    Rupec RA; Boneberger S; Ruzicka T
    Dtsch Med Wochenschr; 2007 Dec; 132(50):2685-94. PubMed ID: 18058660
    [No Abstract]   [Full Text] [Related]  

  • 8. Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.
    Darrigade AS; Milpied B; Truchetet ME; Schaeverbeke T; Laharie D; Zerbib F; Beylot-Barry M; Jouary T; Taïeb A; Ezzedine K; Seneschal J
    Acta Derm Venereol; 2017 Jun; 97(6):731-734. PubMed ID: 28218339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytic infiltration of the skin (Jessner-Kanof) but not reticular erythematous mucinosis occasionally represents clinical manifestations of Borrelia-associated pseudolymphoma.
    Ziemer M; Eisendle K; Müller H; Zelger B
    Br J Dermatol; 2009 Sep; 161(3):583-90. PubMed ID: 19486001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern analysis of drug-induced skin diseases.
    Justiniano H; Berlingeri-Ramos AC; Sánchez JL
    Am J Dermatopathol; 2008 Aug; 30(4):352-69. PubMed ID: 18645307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases.
    Seneschal J; Milpied B; Taieb A
    Chem Immunol Allergy; 2012; 97():203-16. PubMed ID: 22613864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.
    Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K
    Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overview.
    Pirard D; Arco D; Debrouckere V; Heenen M
    Dermatology; 2006; 213(3):182-6. PubMed ID: 17033165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New histopathologic findings in drug eruptions.
    Fitzpatrick JE
    Dermatol Clin; 1992 Jan; 10(1):19-36. PubMed ID: 1530913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical overview: adverse cutaneous reactions to psychotropic medications.
    Kimyai-Asadi A; Harris JC; Nousari HC
    J Clin Psychiatry; 1999 Oct; 60(10):714-25; quiz 726. PubMed ID: 10549695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasiform eruptions during anti TNF-alpha treatment: psoriasis or not?
    Seneschal J; Lepreux S; Milpied B; Schaeverbeke T; Taïeb A
    Arch Dermatol; 2007 Dec; 143(12):1593-5; author reply 1595. PubMed ID: 18087021
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse reactions in the skin from anti-hypertensive drugs.
    Thestrup-Pedersen K
    Dan Med Bull; 1987 Dec; 34 Suppl 1():3-5. PubMed ID: 2893692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side effects of beta receptor blockers on the skin. Review and personal observations].
    Hödl S
    Hautarzt; 1985 Oct; 36(10):549-57. PubMed ID: 2866169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous drug reactions].
    Lützow-Holm C; Rønnevig JR
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2483-7. PubMed ID: 16186866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.